Hodgkin's Disease Clinical Trials

Duarte : City of Hope

A Phase II Study of Brentuximab Vedotin as Salvage Therapy for Hodgkin Lymphoma Prior to Autologous Hematopoietic Stem Cell Transplantation

Duarte : City of Hope

CTSU/CALGB 50604- Phase II Trial of Response- Adapted Chemotherapy Based on Positron Emission Tomography for Non-Bulky Stage I and II Hodgkin Lymphoma

Duarte : City of Hope

Long-Term Follow Up of Recipients of Gene Transfer Research at City of Hope

Duarte : City of Hope

PHI-67, NCI #9091: Phase I Study of the Aurora Kinase A Inhibitor MLN8237 in Combination with the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies

View More »

Los Angeles : Childrens Hospital Los Angeles

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Stanford : Stanford University School of Medicine

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Baltimore : Johns Hopkins Medical Institutions

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

NY : Columbia University Medical Center

A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred

Stony Brook : Stony Brook University Hospital

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease